Elie TOLEDANO

Global Project Coordinator
Acticor Biotech
Paris, Ile-de-France, France

Presentation(s):

• PB0364 - Glycoprotein VI-targeted antiplatelet therapy with glenzocimab is safe in patients exposed to current antithrombotic and fibrinolytic drugs.

  Sunday, June 25, 2023
  18:30 – 19:30 ET